Trial Profile
Exacerbation Rates Among Severe COPD Patients Prescribed Roflumilast in Sweden During Year 2011
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 19 Aug 2015 New trial record